Chronic myelogenous leukemia historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
In the 1840s, the first cases of chronic myelogenous leukemia ([[splenomegaly]] with high [[leukocyte]] count) was reported in France, Germany, and Scotland. In 1960, the association of [[Philadelphia chromosome]] with the pathogenesis of chronic myelogenous leukemia was first discovered. In 1973, (9;22) translocation was first discovered. Definition of the [[BCR (gene)|breakpoint cluster region (BCR)]] on chromosome 22 was first reported in 1984 and the demonstration of the BCR-ABL transcript in CML was first discovered in 1985. From 1980 onwards [[allogeneic stem cell transplantation]] (SCT) became the treatment of choice for eligible patients. In 1998, the era of [[tyrosine kinase inhibitors]] (TKI) began.17671636/20875546 | In the 1840s, the first cases of chronic myelogenous leukemia ([[splenomegaly]] with high [[leukocyte]] count) was reported in France, Germany, and Scotland. In 1960, the association of [[Philadelphia chromosome]] with the pathogenesis of chronic myelogenous leukemia was first discovered. In 1973, (9;22) translocation was first discovered. Definition of the [[BCR (gene)|breakpoint cluster region (BCR)]] on chromosome 22 was first reported in 1984 and the demonstration of the BCR-ABL transcript in CML was first discovered in 1985. From 1980 onwards [[allogeneic stem cell transplantation]] (SCT) became the treatment of choice for eligible patients. In 1998, the era of [[tyrosine kinase inhibitors]] (TKI) began.<ref name="pmid17671636">{{cite journal |vauthors=Nowell PC |title=Discovery of the Philadelphia chromosome: a personal perspective |journal=J. Clin. Invest. |volume=117 |issue=8 |pages=2033–5 |date=August 2007 |pmid=17671636 |pmc=1934591 |doi=10.1172/JCI31771 |url=}}</ref><ref name="pmid20875546">{{cite journal |vauthors=Goldman JM |title=Chronic myeloid leukemia: a historical perspective |journal=Semin. Hematol. |volume=47 |issue=4 |pages=302–11 |date=October 2010 |pmid=20875546 |doi=10.1053/j.seminhematol.2010.07.001 |url=}}</ref> | ||
==Historical Perspective== | ==Historical Perspective== | ||
Important dates in chronic myelogenous leukemia: | <ref name="pmid17671636">{{cite journal |vauthors=Nowell PC |title=Discovery of the Philadelphia chromosome: a personal perspective |journal=J. Clin. Invest. |volume=117 |issue=8 |pages=2033–5 |date=August 2007 |pmid=17671636 |pmc=1934591 |doi=10.1172/JCI31771 |url=}}</ref><ref name="pmid20875546">{{cite journal |vauthors=Goldman JM |title=Chronic myeloid leukemia: a historical perspective |journal=Semin. Hematol. |volume=47 |issue=4 |pages=302–11 |date=October 2010 |pmid=20875546 |doi=10.1053/j.seminhematol.2010.07.001 |url=}}</ref> | ||
Important dates in chronic myelogenous leukemia: | |||
* In the 1840s, the first cases of chronic myelogenous leukemia was first reported. | * In the 1840s, the first cases of chronic myelogenous leukemia was first reported. | ||
* In 1960, [[Philadelphia chromosome]] was first discovered by Peter Nowell and David Hungerford. | * In 1960, [[Philadelphia chromosome]] was first discovered by Peter Nowell and David Hungerford. | ||
Revision as of 14:26, 30 July 2018
|
Chronic myelogenous leukemia Microchapters |
|
Differentiating Chronic myelogenous leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic myelogenous leukemia historical perspective On the Web |
|
American Roentgen Ray Society Images of Chronic myelogenous leukemia historical perspective |
|
Chronic myelogenous leukemia historical perspective in the news |
|
Blogs on Chronic myelogenous leukemia historical perspective |
|
Directions to Hospitals Treating Chronic myelogenous leukemia |
|
Risk calculators and risk factors for Chronic myelogenous leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
In the 1840s, the first cases of chronic myelogenous leukemia (splenomegaly with high leukocyte count) was reported in France, Germany, and Scotland. In 1960, the association of Philadelphia chromosome with the pathogenesis of chronic myelogenous leukemia was first discovered. In 1973, (9;22) translocation was first discovered. Definition of the breakpoint cluster region (BCR) on chromosome 22 was first reported in 1984 and the demonstration of the BCR-ABL transcript in CML was first discovered in 1985. From 1980 onwards allogeneic stem cell transplantation (SCT) became the treatment of choice for eligible patients. In 1998, the era of tyrosine kinase inhibitors (TKI) began.[1][2]
Historical Perspective
[1][2] Important dates in chronic myelogenous leukemia:
- In the 1840s, the first cases of chronic myelogenous leukemia was first reported.
- In 1960, Philadelphia chromosome was first discovered by Peter Nowell and David Hungerford.
- In 1973, (9;22) translocation was first discovered.
- From 1980, allogeneic stem cell transplantation (SCT) became the treatment of choice for eligible patients.
- In 1984, definition of the breakpoint cluster region on chromosome 22 was first reported.
- In 1985, the BCR-ABL transcript was first discovered.
- In 1998, the era of tyrosine kinase inhibitors (TKI) began.
References
- ↑ 1.0 1.1 Nowell PC (August 2007). "Discovery of the Philadelphia chromosome: a personal perspective". J. Clin. Invest. 117 (8): 2033–5. doi:10.1172/JCI31771. PMC 1934591. PMID 17671636.
- ↑ 2.0 2.1 Goldman JM (October 2010). "Chronic myeloid leukemia: a historical perspective". Semin. Hematol. 47 (4): 302–11. doi:10.1053/j.seminhematol.2010.07.001. PMID 20875546.